Author:
Markman Maurie,Blessing John A.,Moore David,Ball Harrison,Lentz Samuel S.
Subject
Obstetrics and Gynecology,Oncology
Reference19 articles.
1. Chemotherapy for advanced or recurrent gynecologic cancer;Thigpen;Cancer,1987
2. Hexamethylmelamine as second-line therapy in platinum-resistant ovarian cancer;Vergote;Gynecol Oncol,1992
3. Hexamethylmelamine as a single second-line agent in ovarian cancer;Manetta;Gynecol Oncol,1990
4. Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin;Pater;Cancer Treat Rep,1987
5. Hexamethylmelamine/altretamine as second-line therapy for epithelial ovarian carcinoma;Moore;Gynecol Oncol,1993
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ovarian, Vaginal, and Vulvar Cancer;Fundamentals of Cancer Detection, Treatment, and Prevention;2022-05-13
2. Design, Synthesis, DFT Studies and Anticancer Activity of Novel Metal Complexes Containing 1,3,5-triazino[1,2-a]benzimidazole Moiety Using Microwave as an Approach for Green Chemistry;Egyptian Journal of Chemistry;2020-08-02
3. Anticancer altretamine recognition by bovine serum albumin and its role as inhibitor of fibril formation: Biophysical insights;International Journal of Biological Macromolecules;2019-10
4. Understanding the structure, electronic properties, solubility in water, and protein interactions of three novel nano-devices against ovarian cancer: a computational study;Journal of Nanoparticle Research;2018-09-28
5. Neurological Complications of Chemotherapy;Cancer Neurology in Clinical Practice;2017-09-17